Tps:// creativecommons.org/licenses/by/ four.0/).Cancers 2021, 13, 4302. https://doi.org/10.3390/cancershttps://www.mdpi.com/journal/cancersCancers 2021, 13,2 ofResults: RelA/p65KD decreased the proliferation and

Tps:// creativecommons.org/licenses/by/ four.0/).Cancers 2021, 13, 4302. https://doi.org/10.3390/cancershttps://www.mdpi.com/journal/cancersCancers 2021, 13,2 ofResults: RelA/p65KD decreased the proliferation and tumour development of human NSCLC cells grown in vivo as xenografts in immunecompromised mice. Ecabet…

Tps:// creativecommons.org/licenses/by/ 4.0/).Cancers 2021, 13, 4302. https://doi.org/10.3390/cancershttps://www.mdpi.com/journal/cancersCancers 2021, 13,2 ofResults: RelA/p65KD decreased the proliferation and

Tps:// creativecommons.org/licenses/by/ 4.0/).Cancers 2021, 13, 4302. https://doi.org/10.3390/cancershttps://www.mdpi.com/journal/cancersCancers 2021, 13,2 ofResults: RelA/p65KD decreased the proliferation and tumour development of human NSCLC cells grown in vivo as xenografts in immunecompromised mice. RNAseq…